Future studies could also examine the relationship between HHLA2 and CAFs in the stromal microenvironment, and whether CAFs induce tumor progression by modulating the immunosuppressive stromal microenvironment through the activation of s-HHLA2. The gene discussed is TBX1; the disease is neoplasm.